Sutro Biopharma Stock

Sutro Biopharma Net Margin

The Net Profit Margin of Sutro Biopharma (STRO) as of Jul 27, 2026 is -186.45 %. In the previous year, Net Profit Margin was -366.62 % — a change of -49.14% (higher).

Net Margin

-186.45 %

YoY

-49.14%

Last updated:

Net Profit Margin of Sutro Biopharma is 2026 -186.45 % . Net Profit Margin of Sutro Biopharma was 2025 -366.62 % . It decreases by -49.14% higher compared to the previous year.

For Sutro Biopharma, the net margin of -316.3% is down versus -179.7% a few years ago.

Access this data via the Eulerpool API

Sutro Biopharma Stock analysis

What does Sutro Biopharma do? Sutro Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sutro Biopharma stock

Net Profit Margin of Sutro Biopharma is -186.45 % in 2026.

Access this data via the Eulerpool API

Margins — Sutro Biopharma

All Key Metrics — Sutro Biopharma